Yonghe Medical Group Co (HKSE:02279) Cash Flow for Dividends: HK$0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02279 Yonghe Medical Group Co Ltd HKSE:02279
84 GF Score
Price HK$2.49
GF Value HK$2.01
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Yonghe Medical Group Co Cash Flow for Dividends?

Yonghe Medical Group Co HKSE:02279 +5.51% 84 Cash Flow for Dividends is HK$0 Mil as of Jun. 2026. GuruFocus rates HKSE:02279 with a GF Score™ of 84/100 and a GF Value™ of HK$2.01 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Yonghe Medical Group Co's cash flow for dividends for the six months ended in Jun. 2026 was HK$0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Jun. 2026 was HK$0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Yonghe Medical Group Co Cash Flow for Dividends Related Terms

Yonghe Medical Group Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Yonghe Medical Group Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yonghe Medical Group Co Cash Flow for Dividends Chart

Yonghe Medical Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial -85.47 -48.20 0.00 0.00 0.00

Yonghe Medical Group Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:02279
84GF Score
Yonghe Medical Group Co Ltd HKSE:02279
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yonghe Medical Group Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of HK$0 Mil mean?
Yonghe Medical Group Co (HKSE:02279) has a Cash Flow for Dividends of HK$0 Mil as of Jun. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Yonghe Medical Group Co and its competitors.
Is Yonghe Medical Group Co's Cash Flow for Dividends too high?
Yonghe Medical Group Co's current Cash Flow for Dividends is HK$0 Mil. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's Cash Flow for Dividends compare to HCA and THC?
Yonghe Medical Group Co's Cash Flow for Dividends of HK$0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Healthcare Providers & Services company?
A good Cash Flow for Dividends depends on the Healthcare Providers & Services industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Yonghe Medical Group Co and its competitors. Yonghe Medical Group Co's current Cash Flow for Dividends is HK$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Yonghe Medical Group Co (HKSE:02279) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$2.01, compared to a current price of HK$2.49 — trading 23.9% above its estimated fair value. The current Cash Flow for Dividends is HK$0 Mil. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Yonghe Medical Group Co (HKSE:02279), the current Cash Flow for Dividends is HK$0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Yonghe Medical Group Co (HKSE:02279) Overvalued in 2026?

Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued. The current stock price of HK$2.49 is trading 23.9% above its estimated GF Value™ of HK$2.01. GuruFocus considers Yonghe Medical Group Co to be Modestly Overvalued.

Key valuation signals for HKSE:02279:

  • Cash Flow for Dividends: HK$0 Mil
  • GF Value™: HK$2.01 vs. price of HK$2.49 (23.9% above fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the HKSE:02279 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Yonghe Medical Group Co Business Description

Other Exchanges L97:Germany
Address Office Tower No. 12B, Chaowai Street, 16th Floor, KunTai International Building, Chaoyang District, Beijing, CHN, 100020
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score

Get the complete analysis for HKSE:02279

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.49
Price
HK$2.01
GF Value